Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29408 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Tianyi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Vaccines have demonstrated remarkable effectiveness in protecting against COVID‐19; however, concerns regarding vaccine‐associated enhanced respiratory diseases (VAERD) following breakthrough infections have emerged. Spike protein subunit vaccines for SARS‐CoV‐2 induce VAERD in hamsters, where aluminum adjuvants promote a Th2‐biased immune response, leading to increased type 2 pulmonary inflammation in animals with breakthrough infections. To gain a deeper understanding of the potential risks and the underlying mechanisms of VAERD, we immunized ACE2‐humanized mice with SARS‐CoV‐2 Spike protein adjuvanted with aluminum and CpG‐ODN. Subsequently, we exposed them to increasing doses of SARS‐CoV‐2 to establish a breakthrough infection. The vaccine elicited robust neutralizing antibody responses, reduced viral titers, and enhanced host survival. However, following a breakthrough infection, vaccinated animals exhibited severe pulmonary immunopathology, characterized by a significant perivascular infiltration of eosinophils and CD4 + T cells, along with increased expression of Th2/Th17 cytokines. Intracellular flow cytometric analysis revealed a systemic Th17 inflammatory response, particularly pronounced in the lungs. Our data demonstrate that aluminum/CpG adjuvants induce strong antibody and Th1‐associated immunity against COVID‐19 but also prime a robust Th2/Th17 inflammatory response, which may contribute to the rapid onset of T cell‐mediated pulmonary immunopathology following a breakthrough infection. These findings underscore the necessity for further research to unravel the complexities of VAERD in COVID‐19 and to enhance vaccine formulations for broad protection and maximum safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA.
- Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.
- Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.
ORCID-Profile: Konstantin G Kousoulas
Förderung
- NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- Louisiana State University
- National Institutes of Health
Zitieren
APA
Zhang, T., Magazine, N., McGee, M. C., Carossino, M., Veggiani, G., Kousoulas, K. G., August, A., & Huang, W. (2024). Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice. Journal of Medical Virology. https://doi.org/10.1002/jmv.29408
Vancouver
Zhang T, Magazine N, McGee MC, Carossino M, Veggiani G, Kousoulas KG, et al. Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice. Journal of Medical Virology. 2024. doi:10.1002/jmv.29408
BibTeX
@article{Zhang2024,
author = {Zhang, Tianyi and Magazine, Nicholas and McGee, Michael C and Carossino, Mariano and Veggiani, Gianluca and Kousoulas, Konstantin G and August, Avery and Huang, Weishan},
title = {Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29408}
}
EUVIMED